[1]姬秋和 陈莉明 郗光霞 余学锋 洪天配 邹大进 秦贵军7 杨刚毅8.2型糖尿病患者体重管理专家共识[J].国际内分泌代谢杂志,2022,42(01):78-86.[doi:10.3760/cma.j.cn121383-20211102-11004]
　Ji Qiuhe,Chen Liming,Xi Guangxia,et al.Expert consensus on weight management for type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2022,42(01):78-86.[doi:10.3760/cma.j.cn121383-20211102-11004]
点击复制

2型糖尿病患者体重管理专家共识()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
42
期数:
2022年01期
页码:
78-86
栏目:
指南与共识
出版日期:
2022-01-20

文章信息/Info

Title:
Expert consensus on weight management for type 2 diabetes mellitus
作者:
姬秋和1 陈莉明2 郗光霞3 余学锋4 洪天配5 邹大进6 秦贵军7 杨刚毅8
Author(s):
Ji Qiuhe1;  Chen Liming2;  Xi Guangxia3;  Yu Xuefeng4;  Hong Tianpei5;  Zou Dajing6;  Qin Guijun7;  Yang Gangyi8
关键词:
糖尿病; 2型;  体重波动;  内脏脂肪;  肌少症;  营养不良
Keywords:
Diabetes mellitus;  type 2;  Body weight fluctuation;  Visceral fat;  Sarcopenia;  Malnutrition
DOI:
10.3760/cma.j.cn121383-20211102-11004
摘要:
2型糖尿病(T2DM)的体重管理重要且复杂。临床实践中,T2DM合并超重或肥胖者常见,应予以充分重视。另一方面,在控制超重或肥胖的基础上,还应注重体重管理的质量。单纯以体重指数作为肥胖的评价指标不够全面和客观,因此,减重治疗还应评估患者身体成分(尤其是内脏脂肪)的改变,以“减脂增肌”为目的; 同时,尽量减少或避免减重过程中的体重波动,使体重长期维持在目标水平。
Abstract:
Weight management is pivotal and complicated in the comprehensive management of type 2 diabetes mellitus(T2DM). In clinical practice, T2DM combined with overweight or obesity is more common, but simply using body mass index as evaluating indicator of obesity is not comprehensive and objective. Therefore, the dynamic changes of body composition especially visceral fat should be evaluated for the purpose of reducing fat and increasing muscle; Meanwhile, avoiding the weight fluctuation during weight loss can contribute to long term target of body weight.

参考文献/References:

[1] Neeland IJ,Ross R,Després JP,et al.Visceral and ectopic fat,atherosclerosis,and cardiometabolic disease:a position statement[J].Lancet Diabetes Endocrinol,2019,7(9):715-725. DOI:10.1016/S2213-8587(19)30084-1.
[2] Ross R,Neeland IJ,Yamashita S,et al.Waist circumference as a vital sign in clinical practice:a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity[J].Nat Rev Endocrinol 2020,16(3):177-189.DOI:10.1038/s41574-019-0310-7.
[3] 杨锡让,傅浩坚.运动生理学发展-质疑与思考[M].北京:北京体育大学出版社,2000:140-153.
[4] 张强,周绍酉,闫雪皎,等.体质指数和体脂肪率评价成年人肥胖的比较[J].卫生研究,2019,48(4):573-576.DOI:10.19813/j.cnki.weishengyanjiu.2019.04.023.
[5] World Health Organization:Obesity.Preventing and Managing the Global Endemic.WHO Technical Report Series no 894[R].Geneva:WHO,2000.
[6] World Health Organization.The Asia-Pacific Perspective:Redefining Obesity and Its Treatment[EB/OL].https://www.scienceopen.com/document?vid=688634a9-1f8d-413a-81f8-a6eb9dbe4601,2000.
[7] 中华医学会健康管理学分会,中国营养学会,中国医疗保健国际交流促进会生殖医学分会,中国健康促进基金会,浙江省临床营养中心.超重或肥胖人群体重管理专家共识及团体标准[J].中华健康管理学杂志,2018,12(3):200-207.DOI:10.3760/cma.j.issn.1674-0815.2018.03.003.
[8] Fielding RA,Vellas B,Evans WJ,et al.Sarcopenia:an undiagnosed condition in older adults.Current consensus definition:prevalence,etiology,and consequences.International working group on sarcopenia[J].J Am Med Dir Assoc,2011,12(4):249-256.DOI:10.1016/j.jamda.2011.01.003.
[9] Chen LK,Liu LK,Woo J,et al.Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.DOI:10.1016/j.jamda.2013.11.025.
[10] Kim YH,Kim SM,Han KD,et al.Change in weight and body mass index associated with all-cause mortality in Korea:a nationwide Longitudinal Study[J].J Clin Endocrinol Metab,2017,102(11):4041-4050.DOI:10.1210/jc.2017-00787.
[11] Chen Y,Yang X,Wang J,et al.Weight loss increases all-cause mortality in overweight or obese patients with diabetes:A meta-analysis[J].Medicine(Baltimore),2018,97(35):e12075.DOI:10.1097/MD.0000000000012075.
[12] Gao F,Wang ZJ,Shen H,et al.Impact of obesity on mortality in patients with diabetes:meta-analysis of 20 studies including 250,016 patients[J].J Diabetes Investig,2018,9(1):44-54.DOI:10.1111/jdi.12677.
[13] Coutinho T,Goel K,Corrêa de Sá D,et al.Central obesity and survival in subjects with coronary artery disease:a systematic review of the literature and collaborative analysis with individual subject data[J].J Am Coll Cardiol,2011,57(19):1877-1886.DOI:10.1016/j.jacc.2010.11.058.
[14] Sahakyan KR,Somers VK,Rodriguez-Escudero JP,et al.Normal-weight central obesity:implications for total and cardiovascular mortality[J].Ann Intern Med,2015,163(11):827-835.DOI:10.7326/M14-2525.
[15] Beddhu S,Pappas LM,Ramkumar N,et al.Effects of body size and body composition on survival in hemodialysis patients[J].J Am Soc Nephrol,2003,14(9):2366-2372.DOI:10.1097/01.asn.0000083905.72794.e6.
[16] Hou X,Lu J,Weng J,et al.Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults:a national diabetes and metabolic disorders survey[J].PLoS One,2013,8(3):e57319.DOI:10.1371/journal.pone.0057319.
[17] Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association:national cross sectional study[J].BMJ,2020,369:m997.DOI:10.1136/bmj.m997.
[18] Indulekha K,Anjana RM,Surendar J,et al.Association of visceral and subcutaneous fat with glucose intolerance,insulin resistance,adipocytokines and inflammatory markers in Asian Indians(CURES-113)[J].Clin Biochem,2011,44(4):281-287.DOI:10.1016/j.clinbiochem.2010.12.015.
[19] Wing RR,Lang W,Wadden TA,et al.Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes[J].Diabetes Care,2011,34(7):1481-1486.DOI:10.2337/dc10-2415.
[20] Zomer E,Gurusamy K,Leach R,et al.Interventions that cause weight loss and the impact on cardiovascular risk factors:a systematic review and meta-analysis[J].Obes Rev,2016,17(10):1001-1011.DOI:10.1111/obr.12433.
[21] Look AHEAD Research Group,Gregg EW,Jakicic JM,et al.Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes:a post-hoc analysis of the look AHEAD randomised clinical trial[J].Lancet Diabetes Endocrinol,2016,4(11):913-921.DOI:10.1016/S2213-8587(16)30162-0.
[22] Lean ME,Leslie WS,Barnes AC,et al.Primary care-led weight management for remission of type 2 diabetes(DiRECT):an open-label,cluster-randomised trial[J].Lancet,2018,391(10120):541-551.DOI:10.1016/S0140-6736(17)33102-1.
[23] Schmidt SK,Hemmestad L,MacDonald CS,et al.Motivation and barriers to maintaining lifestyle changes in patients with type 2 diabetes after an intensive lifestyle intervention(The U-TURN Trial):a longitudinal qualitative Study[J].Int J Environ Res Public Health,2020,17(20):7454.DOI:10.3390/ijerph17207454.
[24] Zhang Y,Zhu C,Wen X,et al.Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans[J].Lipids Health Dis,2017,16(1):209.DOI:10.1186/s12944-017-0598-z.
[25] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.DOI:10.3760/cma.j.cn115791-20210221-00095.
[26] Jensen MD,Ryan DH,Apovian CM,et al.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society[J].J Am Coll Cardiol,2014,63(25 Pt B):2985–3023.DOI:10.1016/j.jacc.2013.11.004.
[27] Verheggen RJ,Maessen MF,Greenet DJ,et al.A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet:distinct effects on body weight and visceral adipose tissue[J].Obes Rev,2016,17(8):664-690.DOI:10.1111/obr.12406.
[28] 中国超重肥胖医学营养治疗专家共识编写委员会.中国超重/肥胖医学营养治疗专家共识(2016年版)[J].中华糖尿病杂志,2016,8(9):525-540.DOI:10.3760/cma.j.issn.1674-5809.2016.09.004.
[29] 陈伟,李子建.应用生活方式干预战胜肥胖症[J].中国医学前沿杂志(电子版),2019,11(12):前插1,1-5.DOI:10.12037/YXQY.2019.12-01.
[30] Carter S,Clifton PM,Keogh JB.Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes:a randomized noninferiority trial[J].JAMA Netw Open,2018,1(3):e180756.DOI:10.1001/jamanetworkopen.2018.0756.
[31] Templeman I,Smith HA,Chowdhury E,et al.A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults[J].Sci Transl Me,2021,13(598):eabd8034.DOI:10.1126/scitranslmed.abd8034.
[32] Kay SJ,Fiatarone Singh MA.The influence of physical activity on abdominal fat:a systematic review of the literature[J].Obes Rev,2006,7(2):183-200.DOI:10.1111/j.1467-789X.2006.00250.x.
[33] Donnelly JE,Blair SN,Jakicic JM,et al.American college of sports medicine position stand.Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults[J].Med Sci Sports Exerc,2009,41(2):459-471.DOI:10.1249/MSS.0b013e3181949333.
[34] Trepanowski JF,Kroeger CM,Barnosky A,et al.Effect of Alternate-Day fasting on weight loss,weight maintenance,and cardioprotection among metabolically healthy obese adults:a randomized clinical trial[J].JAMA Intern Med,2017,177(7):930-938.DOI:10.1001/ jamainternmed.2017.0936.
[35] Grgic J,Schoenfeld BJ.Are the hypertrophic adaptations to high and low-load resistance training muscle fiber type specific?[J].Front Physiol,2018,9:402.DOI:10.3389/fphys.2018.00402.
[36] 中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J].中华内分泌代谢杂志,2016,32(8):623-627.DOI:10.3760/cma.j.issn.1000-6699.2016.08.001.
[37] 中国医师协会内分泌代谢科医师分会.2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)[J].中华内分泌代谢杂志,2019,35(6):447-454.DOI:10.3760/cma.j.issn.1000-6699.2019.06.001.
[38] 中华医学会内分泌学分会,中华医学会糖尿病学分会.胰高糖素样肽-1(GLP-1)受体激动剂用于治疗2型糖尿病的临床专家共识[J].中华内科杂志,2020,59(11):836-846.DOI:10.3760/cma.j.cn112138-20200704-00646.
[39] 中华医学会糖尿病学分会,中华医学会内分泌学分会.中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识[J].中华糖尿病杂志,2020,12(6):369-381.DOI:10.3760/cma.j.cn115791-20200419-00233.
[40] Tsapas A,Karagiannis T,Kakotrichi P,et al.Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes:a systematic review and network meta-analysis[J].Diabetes Obes Metab,2021,23(9):2116-2124.DOI:10.1111/dom.14451.
[41] Pratley RE,Aroda VR,Lingvay I,et al.Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes(SUSTAIN 7):a randomised,open-label,phase 3b trial[J].Lancet Diabetes Endocrinol,2018,6(4):275-286.DOI:10.1016/S2213-8587(18)30024-X.
[42] Ji L,Dong X,Li Y,et al.Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China:a 30-week,double-blind,phase 3a,randomized trial[J].Diabetes Obes Metab,2021,23(2):404-414.DOI:10.1111/dom.14232.
[43] Zhang Y,Zhu C,Wen X,et al.Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans[J].Lipids Health Dis,2017,16(1):209.DOI:10.1186/s12944-017-0598-z.
[44] 中华医学会外科学分会甲状腺及代谢外科学组,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会.中国肥胖及2型糖尿病外科治疗指南(2019版)[J].中国实用外科杂志,2019,39(4):301-306.DOI:10.19538/j.cjps.issn1005-2208.2019.04.01.
[45] Yeboah P,Hsu FC,Bertoni AG,et al.Body mass index,change in weight,body weight variability and outcomes in type 2 diabetes mellitus(from the ACCORD Trial)[J].Am J Cardiol,2019,123(4):576-581.DOI:10.1016/j.amjcard.2018.11.016.
[46] Bangalore S,Fayyad R,DeMicco DA,et al.Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus[J].Circ Cardiovasc Qual Outcomes,2018,11(11):e004724.DOI:10.1161/CIRCOUTCOMES.118.004724.
[47] Oh TJ,Moon JH,Choi SH,et al.Body-Weight Fluctuation and Incident Diabetes Mellitus,Cardiovascular Disease,and Mortality:A 16-Year Prospective Cohort Study[J].J Clin Endocrinol Metab,2019,104(3):639-646.DOI:10.1210/jc.2018-01239.
[48] Rhee EJ.Weight Cycling and Its Cardiometabolic Impact.J Obes Metab Syndr[J].J Obes Metab Syndr,2017,26(4):237-242.DOI:10.7570/jomes.2017.26.4.237.
[49] Van Gaal L,Scheen A.Weight management in type 2 diabetes:current and emerging approaches to treatment[J].Diabetes Care,2015,38(6):1161-1172.DOI:10.2337/dc14-1630.
[50] Dulloo AG,Jacquet J,Montani JP,et al.How dieting makes the lean fatter:from a perspective of body composition autoregulation through adipostats and proteinstats awaiting discovery[J]Obes Rev,2015,16 Suppl 1:25-35.DOI:10.1111/obr.12253.
[51] Zou H,Yin P,Liu L,et al.Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease,All-Cause and Cardiovascular Mortality:A Systematic Review and Meta-Analysis[J].Front Endocrinol,2019,10:728.DOI:10.3389/fendo.2019.00728.
[52] Li D,Zou H,Yin P,et al.Durability of glycaemic control in type 2 diabetes:A systematic review and meta-analysis for its association with body weight changes[J].Diabetes Obes and Metab,2021,23(1):208-217.DOI:10.1111/dom.14217.
[53] Amato MC,Giordano C,Galia M,et al.Visceral adiposity index:a reliable indicator of visceral fat function associated with cardiometabolic risk[J].Diabetes Care,2010,33(4):920-922.DOI:10.2337/dc09-1825.
[54] Nusrianto R,Tahapary DL,Soewondo P.Visceral adiposity index as a predictor for type 2 diabetes mellitus in Asian population:A systematic review[J].Diabetes Metab Syndr,2019,13(2):1231-1235.DOI:10.1016/j.dsx.2019.01.056.
[55] Durrer Schutz D,Busetto L,Dicker D,et al.European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care[J].Obes Facts,2019,12(1):40-66.DOI:10.1159/000496183.
[56] 中华人民共和国卫生部.WS/T 424-2013 人群健康监测人体测量方法[S].北京:中华人民共和国卫生部,2013.
[57] De Laet C,Kanis JA,Odén A,et al.Body mass index as a predictor of fracture risk:a meta-analysis[J].Osteoporos Int,2005,16(11):1330-1338.DOI:10.1007/s00198-005-1863-y.
[58] Holmberg AH,Johnell O,Nilsson PM,et al.Risk factors for fragility fracture in middle age.A prospective population-based study of 33,000 men and women[J].Osteoporos Int,2006,17(7):1065-1077.DOI:10.1007/s00198-006-0137-7.
[59] Kanazawa I,Notsu M,Takeno A,et al.Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus[J].J Bone Miner Metab,2019,37(4):703-710.DOI:10.1007/s00774-018-0960-x.
[60] Rajamanickam A,Munisankar S,Dolla CK,et al.Impact of malnutrition on systemic immune and metabolic profiles in type 2 diabetes[J].BMC Endocr Disord,2020,20(1):168.DOI:10.1186/s12902-020-00649-7.
[61] Boutari C,Pappas PD,Mintziori G,et al.The effect of underweight on female and male reproduction[J].Metabolism,2020,107:154229.DOI:10.1016/j.metabol.2020.154229.
[62] Luque EM,Tissera A,Gaggino MP,et al.Body mass index and human sperm quality:neither one extreme nor the other[J].Reprod Fertil Dev,2017,29(4):731-739.DOI:10.1071/RD15351.
[63] Kim YH,Kang JG,Lee SJ,et al.Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population:Data From the National Health Insurance Service Health Checkups 2009-2017[J].Diabetes Care,2020,43(5):1118-1125.DOI:10.2337/dc19-2095.
[64] 陈轶愔,彭乐乐,何佩茹,等.2型糖尿病合并衰弱和肌少症的机制与治疗[J].中华老年医学杂志,2021,40(1):124-127.DOI:10.3760/cma.j.issn.0254-9026.2021.01.021.
[65] 吕静,袁丽,李饶.糖尿病性肌少症患者运动干预的研究进展[J].护理学杂志,2021,36(4):105-108.DOI:10.3870/j.issn.1001-4152.2021.04.105.
[66] 吉彤,汤哲,李耘,等.老年人少肌性肥胖预防和治疗策略[J].中华老年医学杂志,2020,39(7):845-849.DOI:10.3760/cma.j.issn.0254-9026.2020.07.026.
[67] Wang J,Yan R,Wen J,et al.Association of lower body mass index with increased glycemic variability in patients with newly diagnosed type 2 diabetes:a cross-sectional study in China[J].Oncotarget,2017,8(42):73133-73143.DOI:10.18632/oncotarget.17111.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(01):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
　Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
[11]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志,2021,41(05):482.[doi:10.3760/cma.j.cn121383-20210825-08063]
[12]《型糖尿病短期胰岛素强化治疗专家共识》编写委员会.2型糖尿病短期胰岛素强化治疗专家共识(2021年版)[J].国际内分泌代谢杂志,2022,42(01):67.[doi:10.3760/cma.j.cn121383-20220114-01028]

备注/Memo

备注/Memo:
通信作者:母义明, Email:muyiming@301hospital.com.cn; 赵家军,Email:jjzhao@sdu.edu.cn 基金项目:国家重点研发计划(2017YFC1309800,2017YFC1309803)
更新日期/Last Update: 2022-01-20